X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Strides Arcolab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs STRIDES SHASUN LTD - Comparison Results

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB STRIDES SHASUN LTD UNICHEM LAB/
STRIDES SHASUN LTD
 
P/E (TTM) x 21.8 14.1 155.0% View Chart
P/BV x 2.3 1.9 120.7% View Chart
Dividend Yield % 0.8 0.5 151.1%  

Financials

 UNICHEM LAB   STRIDES SHASUN LTD
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
STRIDES SHASUN LTD
Mar-16
UNICHEM LAB/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs3341,413 23.6%   
Low Rs174848 20.5%   
Sales per share (Unadj.) Rs146.9353.3 41.6%  
Earnings per share (Unadj.) Rs11.923.4 50.9%  
Cash flow per share (Unadj.) Rs16.241.0 39.5%  
Dividends per share (Unadj.) Rs2.005.00 40.0%  
Dividend yield (eoy) %0.80.4 178.0%  
Book value per share (Unadj.) Rs105.1320.4 32.8%  
Shares outstanding (eoy) m90.8489.35 101.7%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x1.73.2 54.0%   
Avg P/E ratio x21.448.3 44.2%  
P/CF ratio (eoy) x15.727.6 56.9%  
Price / Book Value ratio x2.43.5 68.5%  
Dividend payout %16.821.4 78.6%   
Avg Mkt Cap Rs m23,073100,988 22.8%   
No. of employees `0005.74.7 121.0%   
Total wages/salary Rs m2,5584,988 51.3%   
Avg. sales/employee Rs Th2,352.56,730.0 35.0%   
Avg. wages/employee Rs Th450.91,063.6 42.4%   
Avg. net profit/employee Rs Th190.4445.5 42.7%   
INCOME DATA
Net Sales Rs m13,34631,564 42.3%  
Other income Rs m1921,212 15.8%   
Total revenues Rs m13,53832,776 41.3%   
Gross profit Rs m1,6395,213 31.4%  
Depreciation Rs m3901,573 24.8%   
Interest Rs m291,803 1.6%   
Profit before tax Rs m1,4123,049 46.3%   
Minority Interest Rs m0127 0.0%   
Prior Period Items Rs m-4-27 13.8%   
Extraordinary Inc (Exp) Rs m-35-371 9.5%   
Tax Rs m293689 42.5%   
Profit after tax Rs m1,0802,089 51.7%  
Gross profit margin %12.316.5 74.4%  
Effective tax rate %20.722.6 91.8%   
Net profit margin %8.16.6 122.3%  
BALANCE SHEET DATA
Current assets Rs m5,97935,949 16.6%   
Current liabilities Rs m2,43219,402 12.5%   
Net working cap to sales %26.652.4 50.7%  
Current ratio x2.51.9 132.7%  
Inventory Days Days6371 88.9%  
Debtors Days Days60127 47.6%  
Net fixed assets Rs m6,40334,478 18.6%   
Share capital Rs m182894 20.3%   
"Free" reserves Rs m9,29322,601 41.1%   
Net worth Rs m9,54828,632 33.3%   
Long term debt Rs m23027,455 0.8%   
Total assets Rs m12,84376,591 16.8%  
Interest coverage x50.02.7 1,859.1%   
Debt to equity ratio x01.0 2.5%  
Sales to assets ratio x1.00.4 252.2%   
Return on assets %8.65.1 169.9%  
Return on equity %11.37.3 155.1%  
Return on capital %14.38.2 175.5%  
Exports to sales %29.248.1 60.7%   
Imports to sales %6.314.5 43.9%   
Exports (fob) Rs m3,90015,192 25.7%   
Imports (cif) Rs m8474,565 18.5%   
Fx inflow Rs m4,35616,612 26.2%   
Fx outflow Rs m1,1625,292 22.0%   
Net fx Rs m3,19411,320 28.2%   
CASH FLOW
From Operations Rs m1,119717 156.2%  
From Investments Rs m-853-22,284 3.8%  
From Financial Activity Rs m-33429,488 -1.1%  
Net Cashflow Rs m-688,073 -0.8%  

Share Holding

Indian Promoters % 50.1 27.7 180.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 37.8 39.9%  
FIIs % 3.0 8.6 34.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 25.9 122.4%  
Shareholders   20,176 56,241 35.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   GLENMARK PHARMA  FULFORD INDIA  DR. REDDYS LAB  DIVIS LABORATORIES  ALEMBIC LTD  

Compare UNICHEM LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Aug 23, 2017 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS